Atlas Trials

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Clinical trial NCT03233178 · COMPLETED

Trial details

NCT number
NCT03233178
Sponsor
LMC Diabetes & Endocrinology Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
Start date
2017-01-01
Primary completion
2017-06-01
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.